These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 18564109)
1. Ten-day sequential treatment for Helicobacter pylori eradication in clinical practice. Sánchez-Delgado J; Calvet X; Bujanda L; Gisbert JP; Titó L; Castro M Am J Gastroenterol; 2008 Sep; 103(9):2220-3. PubMed ID: 18564109 [TBL] [Abstract][Full Text] [Related]
2. High-dose, ten-day esomeprazole, amoxicillin and metronidazole triple therapy achieves high Helicobacter pylori eradication rates. Sánchez-Delgado J; García-Iglesias P; Castro-Fernández M; Bory F; Barenys M; Bujanda L; Lisozain J; Calvo MM; Torra S; Gisbert JP; Calvet X Aliment Pharmacol Ther; 2012 Jul; 36(2):190-6. PubMed ID: 22591220 [TBL] [Abstract][Full Text] [Related]
3. Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients. Köksal AS; Parlak E; Filik L; Yolcu OF; Odemiş B; Ulker A; Saşmaz N; Ozden A; Sahin B J Gastroenterol Hepatol; 2005 Apr; 20(4):637-42. PubMed ID: 15836716 [TBL] [Abstract][Full Text] [Related]
4. 2-week triple therapy for Helicobacter pylori infection is better than 1-week in clinical practice: a large prospective single-center randomized study. Paoluzi P; Iacopini F; Crispino P; Nardi F; Bella A; Rivera M; Rossi P; Gurnari M; Caracciolo F; Zippi M; Pica R Helicobacter; 2006 Dec; 11(6):562-8. PubMed ID: 17083378 [TBL] [Abstract][Full Text] [Related]
5. Randomised clinical trial: the efficacy of a 10-day sequential therapy vs. a 14-day standard proton pump inhibitor-based triple therapy for Helicobacter pylori in Korea. Kim YS; Kim SJ; Yoon JH; Suk KT; Kim JB; Kim DJ; Kim DY; Min HJ; Park SH; Shin WG; Kim KH; Kim HY; Baik GH Aliment Pharmacol Ther; 2011 Nov; 34(9):1098-105. PubMed ID: 21923713 [TBL] [Abstract][Full Text] [Related]
6. Improved efficacy of 10-Day sequential treatment for Helicobacter pylori eradication in children: a randomized trial. Francavilla R; Lionetti E; Castellaneta SP; Magistà AM; Boscarelli G; Piscitelli D; Amoruso A; Di Leo A; Miniello VL; Francavilla A; Cavallo L; Ierardi E Gastroenterology; 2005 Nov; 129(5):1414-9. PubMed ID: 16285942 [TBL] [Abstract][Full Text] [Related]
7. Ten-day sequential therapy is more effective than proton pump inhibitor-based therapy in Korea: a prospective, randomized study. Oh HS; Lee DH; Seo JY; Cho YR; Kim N; Jeoung SH; Kim JW; Hwang JH; Park YS; Lee SH; Shin CM; Cho HJ; Jung HC; Song IS J Gastroenterol Hepatol; 2012 Mar; 27(3):504-9. PubMed ID: 21916989 [TBL] [Abstract][Full Text] [Related]
8. The effects of probiotics on PPI-triple therapy for Helicobacter pylori eradication. Kim MN; Kim N; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Kim JS; Jung HC; Song IS Helicobacter; 2008 Aug; 13(4):261-8. PubMed ID: 18665934 [TBL] [Abstract][Full Text] [Related]
9. One-week versus two-week H2-receptor antagonist in combination with amoxicillin and tinidazole for eradication of Helicobacter pylori infection. Hsu CC; Chen JJ; Hu TH; Lu SN; Changchien CS Hepatogastroenterology; 2005; 52(65):1617-21. PubMed ID: 16201128 [TBL] [Abstract][Full Text] [Related]
10. Ten-day sequential therapy of Helicobacter pylori infection in Thailand. Sirimontaporn N; Thong-Ngam D; Tumwasorn S; Mahachai V Am J Gastroenterol; 2010 May; 105(5):1071-5. PubMed ID: 20010919 [TBL] [Abstract][Full Text] [Related]
11. The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori. Uygun A; Kadayifci A; Safali M; Ilgan S; Bagci S J Dig Dis; 2007 Nov; 8(4):211-5. PubMed ID: 17970879 [TBL] [Abstract][Full Text] [Related]
12. Comparative study of Helicobacter pylori eradication rates of twice-versus four-times-daily amoxicillin administered with proton pump inhibitor and clarithromycin: a randomized study. Kim SY; Lee SW; Jung SW; Koo JS; Yim HJ; Park JJ; Chun HJ; Lee HS; Choi JH; Kim CD; Ryu HS Helicobacter; 2008 Aug; 13(4):282-7. PubMed ID: 18665938 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of metronidazole as second-line drug for the treatment of Helicobacter pylori Infection in the Japanese population: a multicenter study in the Tokyo Metropolitan Area. Matsuhisa T; Kawai T; Masaoka T; Suzuki H; Ito M; Kawamura Y; Tokunaga K; Suzuki M; Mine T; Takahashi S; Sakaki N Helicobacter; 2006 Jun; 11(3):152-8. PubMed ID: 16684262 [TBL] [Abstract][Full Text] [Related]
14. Eradication of Helicobacter pylori infection with proton pump inhibitor-based triple therapy. A randomised study. Palmas F; Pellicano R; Massimetti E; Berrutti M; Fagoonee S; Rizzetto M Panminerva Med; 2002 Jun; 44(2):145-7. PubMed ID: 12032434 [TBL] [Abstract][Full Text] [Related]
15. Variables influencing outcome of Helicobacter pylori eradication therapy in South China. Cai W; Zhou L; Ren W; Deng L; Yu M Helicobacter; 2009 Oct; 14(5):91-6. PubMed ID: 19751433 [TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes of two-week sequential and concomitant therapies for Helicobacter pylori eradication: a randomized pilot study. Lim JH; Lee DH; Choi C; Lee ST; Kim N; Jeong SH; Kim JW; Hwang JH; Park YS; Lee SH; Shin CM; Jo HJ; Jang ES; Song Is; Jung HC Helicobacter; 2013 Jun; 18(3):180-6. PubMed ID: 23305083 [TBL] [Abstract][Full Text] [Related]
17. Second-line treatment for Helicobacter pylori infection in Japan: proton pump inhibitor-based amoxicillin and metronidazole regimen. Nagahara A; Miwa H; Kawabe M; Kurosawa A; Asaoka D; Hojo M; Iijima K; Terai T; Ohkusa T; Miyazaki A; Sato N J Gastroenterol; 2004 Nov; 39(11):1051-5. PubMed ID: 15580397 [TBL] [Abstract][Full Text] [Related]
18. Ten-day sequential therapy as first-line treatment for Helicobacter pylori infection in Korea: a retrospective study. Kwon JH; Lee DH; Song BJ; Lee JW; Kim JJ; Park YS; Kim N; Jeong SH; Kim JW; Lee SH; Hwang JH; Jung HC; Song IS Helicobacter; 2010 Apr; 15(2):148-53. PubMed ID: 20402817 [TBL] [Abstract][Full Text] [Related]
19. Comparison of 7-day and 14-day proton pump inhibitor-containing triple therapy for Helicobacter pylori eradication: neither treatment duration provides acceptable eradication rate in Korea. Kim BG; Lee DH; Ye BD; Lee KH; Kim BW; Kim SG; Kim SW; Kim SK; Kim JJ; Kim HY; Park JJ; Park CY; Baik GH; Lee YC; Lee JH; Lee JH; Chun HJ; Hahm KB; Hong SJ; Lee SW; Jung HC Helicobacter; 2007 Feb; 12(1):31-5. PubMed ID: 17241298 [TBL] [Abstract][Full Text] [Related]
20. A pilot study evaluating sequential administration of a PPI-amoxicillin followed by a PPI-metronidazole-tetracycline in Turkey. Sezgin O; Altintaş E; Nayir E; Uçbilek E Helicobacter; 2007 Dec; 12(6):629-32. PubMed ID: 18001405 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]